ABERCROMBIE GEORGE B 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Nov 17, 2021
Insider Transaction Report
Form 4
ABERCROMBIE GEORGE B
Director
Transactions
- Exercise/Conversion
Automatic Stock Option Grant
2021-11-15−5,000→ 10,000 totalExercise: $3.32Exp: 2022-05-23→ Common Stock (5,000 underlying) - Sale
Common Stock
2021-11-15$12.27/sh−5,000$61,350→ 0 total - Exercise/Conversion
Common Stock
2021-11-15$3.32/sh+5,000$16,600→ 5,000 total
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
- [F2]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.22 to $12.29. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- [F3]The option vested 1/12 per month for a period of 12 months, beginning on June 23, 2012.